VASOCONSTRICTION References

1.            Burgess KR. Central sleep apnoea and heart failure (part II). Respirology 3: 1-11, 1998.

2.            Chiariello M, and Perrone-Filardi P. Pathophysiology of heart failure. Miner Electrolyte Metab 25: 6-10, 1999.

3.            Gabrielsen A, Sorensen VB, Pump B, Galatius S, Videbaek R, Bie P, Warberg J, Christensen NJ, Wroblewski H, Kastrup J, and Norsk P. Cardiovascular and neuroendocrine responses to water immersion in compensated heart failure. Am J Physiol Heart Circ Physiol 279: H1931-1940, 2000.

4.            Manthey J, Dietz R, Opherk D, Osterziel KJ, Leinberger H, and Kubler W. Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness. Am J Cardiol 70: 224-228, 1992.

5.            Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 119: S47-53, 2006.

6.            Schweiger TA, and Zdanowicz MM. Vasopressin-receptor antagonists in heart failure. Am J Health Syst Pharm 65: 807-817, 2008.

7.         Sica DA. Sodium and water retention in heart failure and diuretic therapy: basic mechanisms. Cleve Clin J Med 73 Suppl 2: S2-7; discussion S30-33, 2006.